In addition, similar results were validated in the two cohorts of patients with WHO grade III and IV gliomas, although the grade II subgroup failed to reach statistical significance.
← all excerpts
Molecular and immunological features of TREM1 and its emergence as a prognostic indicator in glioma.
1
—
—